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The 3D printing process can produce bioengineered scaffolds with a 100% interconnected 
porous structure layer-by-layer with the help of computer-aided design. In this study we 
utilized a 3D bio plotter system to fabricate 3D interconnected porous scaffolds for bone 
tissue engineering. Poly (L-lactide-co-caprolactone (PLCL)) was selected to fabricate the 
scaffold due to its biocompatibility and printability. Two scaffolds were produced for 
comparative study with a layer rotation of 45° and 90° and a distance of either 1000 µm or 
1200 µm between the printed fibers.  
Micro computed tomography (µ-CT) was utilized to study the interconnected porous 
structure of the scaffolds. Protein adsorption on the surface of the scaffolds was examined 
using a protein assay kit. Human osteoblast-like cells (HOB) were seeded onto the two 
different scaffolds and cellular activities (attachment, morphology, and proliferation) were 
investigated using scanning electron microscopy (SEM), live/dead stain, lactate 
dehydrogenase enzyme (LDH), and methylthiazol tetrazolium (MTT). Gene expression of 
apoptotic (Bax and Bcl2) and osteogenic markers (ALP and OC) were investigated by qRT-
PCR.  The µ-CT results confirmed the open porous structure of the two scaffolds and no 
significant difference was found in protein adsorption between the two designs. SEM, LDH 
and MTT analysis confirmed that HOB cells adhered, spread and proliferated well on both 
scaffolds. The qRT-PCR analysis showed that cells seeded on the scaffold with 1200 µm 
between the fibers expressed higher mRNA levels of Bcl2 (day 1, 3, 7 and 14), ALP and OC 
than cells seeded on the scaffold with 1000 µm between fibers (day 14). 
In conclusion, the newly designed 3D printed scaffolds are biocompatible with HOBs, 
and no adverse effect on cell attachment and proliferation was seen. Rather, enhanced 
osteoblast proliferation and differentiation were seen using the scaffold with 1200 µm 
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between the printed fibers. Therefore, 1200 3D printed poly (L-lactide-co-caprolactone) 
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Acronyms and Abbreviations 
 
2D                     2-dimentional 
3D      3-dimensional 
3DP                  3-dimensional plotting  
 AB                     Antibiotics 
ALP                    Alkaline phosphatase 
α-MEM               Minimum essential medium, alpha modification 
BTE                    Bone tissue engineering 
DMEM               Dulbecco’s modified Eagle’s medium 
ECM                   Extra cellular Matrix 
FBS                     Fetal Bovine Serum 
FDA                   Food and Drug Administration 
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 −ΔΔ
Ct method   Comparative CT method for relative quantification 
cDNA                 Complementary deoxyribonucleic Acid 
GAPDH              Glyceraldehyde-3-phosphate dehydrogenase 
HOBs                  Human osteoblast-like cells 
L929                   Mouse fibroblast cell line 
LDH                   Lactic Dehydrogenase Based 
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L&D                   Live and Dead 
µCT                    Microcomputed tomography 
mRNA                 Messenger ribonucleic acid 
MTT                   Methylthiazol tetrazolium 
OC                      Osteocalcin 
PBS                     Phosphate buffered saline 
PLCL                  Poly (L-lactide-co-caprolactone) 
SEM                     Scanning electron microscopy 
qRT-PCR             Quantitative Reverse Transcription-Polymerase Chain 
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Organ failure and dysfunction caused by damaged or diseased tissue is increasing due to 
trauma, sickness and the aging population, all of which can drastically affect the quality of 
life. The current need for organ or tissue replacement is increasing. Bone tissue engineering 
has therefore been of increasing interest recently as a potential alternative to the use of bone 
grafts as a way to heal bone defects and restore lost bone.  That is, treatment of bone defects 
via bone tissue engineering now aims to encourage new, functional bone regeneration by 
combining three main components: a rich source of osteoprogenitor cells, biocompatible 
scaffolds favorable to maintenance of cell function and osteoinductive growth factors.  
  Biodegradable 3D printed scaffolds were used in the present study to provide a 
microenvironment that supports cell attachment, proliferation and differentiation, thus 
inducing functional bone tissues. The specific aim of the study was to evaluate the effect of 
the distance between the printed fibers of the scaffold on these biological responses. Poly 
(LLA-co-CL) scaffolds were generated for the study and printed with a distance of either 
1000 µm or 1200 µm between the fibers.  
            The scaffolds were characterized and seeded with human osteoblast-like cells (HOBs) 
to investigate the cells’ ability to attach, proliferate and differentiate on the two different 
scaffolds. 
 The results showed that the 3D scaffolds are not cytotoxic, are biocompatible and do 
not have an adverse effect on the attachment and proliferation of HOBs in vitro. Moreover, 
the 1200 µm scaffold enhanced proliferation and expression of osteogenic markers by HOBs 
compared to the 1000 µm scaffold in vitro. Therefore, the 1200 µm 3D printed scaffold 
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1.1. Tissue Engineering and the concept of tissue engineering 
 
Tissue engineering (TE) was defined by Langer and Vacanti  in 1993 as “an inter disciplinary 
field of research that applies the principles of engineering  and life sciences towards the 
development of biological substitutes that restore, maintain, or improve tissue function" (1).  
TE requires a rich source of osteoprogenitor cells to repair defective bone tissue and a 
scaffold to encourage the attachment of the cells in combination with a specific growth factor 
or factors (signaling molecules) (1, 2). The scaffold should degrade in time when the tissue 
has matured, while permitting the newly forming tissue to function during the period of 
regeneration (3). 
As the result of substantial collaborative efforts between scientists, engineers, and 
surgeons TE is developing rapidly as a potential alternative for human organ and tissue 
transplant (4), especially in the area of engineered bone grafts to enhance bone repair and 
regeneration (5). New advances in the field of bone tissue engineering have involved the use 
of biocompatible scaffolds, new perinatal multipotent cells, and the suitable cellular 
stimulation with growth factors and signaling molecules (6).  
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Figure 2. The three major components of bone tissue engineering 
1.2.  Bone tissue engineering (BTE) 
 
By 2020 the worldwide prevalence of bone disorders is expected to double, especially in 
populations where aging is coupled with increasing obesity, and poor physical activity (7). 
Rehabilitation of bone defects as a result of congenital defects, trauma and tumor presents a 
clinical challenge using current therapeutic approaches (8). Biological grafts can be 
subdivided into autografts (bone tissue from the same individual), allografts (bone tissue from 
another individual of the same species), and xenografts (bone tissue from other species) (9, 
10). Bone tissue engineering is therefore a field of rapidly growing interest as it has been 
suggested as an alternative to the current use of autologous and allogenic bone grafts, which 
have the drawbacks of limited supply, difficulty in shaping and potential for disease 
transmission (7). Bone tissue engineering thus appears to be a promising approach to improve 
human health through prevention of disease and restoration functions of healthy tissue (11). 
 
Cells     











The objectives of bone tissue engineering are to induce new functional bone through the 
synergistic combination of cells, growth factors and scaffolds (7). Bone tissue engineering is 
based on the current  understanding of bone mechanics, structure, and tissue formation as it 
pertains to stimulating new functional bone tissues (7). During the next 25 years bone tissue 
engineering is expected to have  a significant effect on dental and medical practice (12).  
Scaffolds suitable for bone tissue engineering should fulfill certain basic requirements, 
i.e.: stimulation of progenitor cells to differentiate into cells of the osteoblastic lineage 
(Osteoinduction), encourages bone growth and the ingrowth of surrounding tissue 
(Osteoconduction) (13). 
 
Figure3. Cells isolated from a biopsy, seeded in vitro on an appropriate scaffold (provisional 




1.3. Cells for tissue engineering  
 
Both hematopoietic stem cells that produce cells of all hematopoietic lineages and human 
mesenchymal stem cells (hMSC) are found in adult human bone marrow (14). Mesenchymal 
stem cells (MSC) are potentially able to differentiate into multiple cell linages in vitro, or in 
vivo, and have great capacity for self-renewal, leading to tissue regeneration as a basic part of 
the concept of TE. MSC have been shown to have the ability to differentiate into osteocytes, 
chondrocytes, myocytes and neurons in vitro and in vivo (2, 15, 16). MSC are mainly found in 
the bone marrow but can also be isolated from other tissue sources (17, 18).  
Osteoblasts synthesize and secrete alkaline phosphatase (ALP), collagen type 1, and 
other noncollagenous extracellular bone matrix proteins such as osteocalcin (OC) and 
osteopontin.  ALP plays an important role in the mineralization of the bone, while OC plays 
an important role in the ossification process of bone formation, making all of these useful 
markers of the various stages of osteogenesis, from cell proliferation and matrix synthesis to 
matrix mineralization (19).   
1.4. Growth factors in bone regeneration 
 
Growth factors are cytokines secreted by different types of cells and function as signaling 
molecules. They promote and/or prevent proliferation and differentiation of the cell (2). Thus, 
they are essential for tissue formation. Several growth factors are expressed and have 
reasonable effects on and during bone formation, such as fibroblast growth factor (FGF), bone 
morphogenetic proteins (BMPs), insulin-like growth factor (IGF), transforming growth factor 





1.5. Scaffolds in bone tissue engineering 
 
A scaffold is a three-dimensional (3D) template for initial cell adhesion, proliferation and 
tissue regeneration (21-24). As reported by Hutmacher (24) the ideal scaffold for TE should 
be well integrated in the host’s tissue with no immunological response. Moreover, it should 
have appropriate surface properties for cell attachment, proliferation and differentiation, and 
should have high porosity to facilitate transport of nutrients and metabolic waste. Scaffolds 
also require excellent biocompatibility, with controllable degradation and resorption rates to 
mimic normal tissue and organs, and good mechanical properties to match the rate of tissue 
growth in vitro and in vivo (24, 25).  Biocompatibility is the ability of a device or biomaterial 
to perform as a substrate that supports appropriate cellular activity, or performs with the 
desired host response in order to optimize tissue regeneration (26). Cytotoxicity testing is 
generally performed to detect cell death or other serious negative effects on cellular functions 
at an early stage in the testing process. Cytotoxicity testing serves as a reproducible screening 
method, must be appropriate, and serve as a dependable test in vitro (27). Apoptotic activity is 
a sign of cell viability; both Bcl-2 (anti-apoptotic) and Bax (pro-apoptotic) are important 
regulators of apoptosis and play a crucial role in the regulation of cellular apoptosis. The 
balance between these genes therefore represents a measure of overall apoptotic activity (28).  
Both natural and synthetic scaffold materials have been proposed for bone TE, 
including metals, ceramics and polymers (21). Metals: The good mechanical properties of 
metals make them excellent, if not the best choice, for implantable medical devices. Although 
metal has greater strength than the hard tissues of the body due to its stiffness, its lack of 
degradability in a biological environment is a drawback in scaffold fabrication (29, 30).  
Ceramics: include both naturally derived materials like coralline hydroxyl apatite (HA) and 
synthesized materials such as synthetic HA. The osteoinductive and osteoconductive 
properties of ceramics have led to their use in biomedical engineering and bone regeneration. 
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However, their low mechanical stability, brittleness, and stiffness that may give them 
increased strength relative to biologic hard tissue are significant disadvantages that prevent 
their use in regeneration of large bone defects (21, 29, 30). Polymers: are thermoplastics and 
have wide flexibility in physical properties, permitting them to be tailored to specific uses, 
and can be easily formed into desired shapes (30, 31).   
There are two types of biodegradable scaffolds, natural and synthetic. The natural 
scaffolds are derived from natural sources such as collagen, fibrinogen, polysaccharides 
(starch, alginate, chitin/chitosan, hyaluronic) or proteins. These materials facilitate cell 
attachment, differentiation, migration, and tissue vascularization (21). The synthetic scaffold 
is more commonly used for tissue engineering and bone regeneration than the natural (32, 33).  
There are many types of synthetic biodegradable polymers that have been used widely 
for TE. Poly (glycolic acid) (PGA) has high tensile strength with low solubility and can cause 
inflammatory reactions (33, 34). Poly (ɛ-caprolacton) (PCL) is highly compatible and has 
been examined as a material for controlled delivery of drugs due to its low degradation rate 
and high solubility in organic solvents (33, 35-37). Poly (lactic acid) (PLA) has desirable 
processing and mechanical properties and as a result of its low degradation rate is widely used 
as fixative devices in bone fracture, clinical products for drug delivery, sutures, guided tissue 
regeneration (in dental applications), and scaffolds for TE. Four different types of PLA are 
available but only poly (l-lactic acid) and poly (dl-lactic acid) have been widely investigated 
as biomaterials (33, 34). Scaffolds of poly (LLA) are biodegradable scaffolds that have been 
tested as alternatives to ceramic (36, 38). Poly (LLA) has been used in medical and orthopedic 
devices such as a bone fixator under the product names Fixsorb
® 
(39), a resorbable suture 
Vicryl
®
 and Phantom Suture Anchor
® 
(40). It has been suggested that copolymers such as 
Poly (L-Lactide-co-caprolactone) {poly (LLA-co-CL)} are appropriate materials for 
enhancing bone tissue regeneration (35, 36, 41). These copolymers possess desirable 
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mechanical properties, good biocompatibility and degradability that can be used to produce 
scaffolds and increase function of cells attachment and proliferation (40, 42).  
             The synthetic scaffold can be designed using a variety of methods. The chemical/gas 
foaming method can be used to create porous structures in a continuous extrusion process, 
using a high pressure carbon dioxide gas, until saturation of the polymer mix, followed by a 
foaming process. This method is widely used industrially to produce closed cell thermoplastic 
foams, and a precise pore size distribution and porosity can be achieved that help cell 
infiltration, and provide suitable mechanical behavior (43). The solvent casting, particle/salt 
leaching method depends totally on the evaporation of the solvents. Using this technique is 
easy and there is no need for particular equipment during scaffolds fabrication, and there is 
therefore a low cost method. The freeze drying method has been used to fabricate scaffolds 
with high porosity and interconnectivity, depending on sublimation. The solution of dissolved 
polymer is frozen and the solvent is removed under high vacuum (44). However, each of these 
methods has some disadvantages; for example the use of highly toxic solvents, thin structure 
limitation, retention of particles in the scaffolds matrix, irregularity in pores size and shape, 
smaller pore size and long processing time (32, 45).          
3D printed scaffolds are therefore being developed to overcome these problems (45). 
These scaffolds are designed for better blood vessel formation, ultimately leading to better 
bone formation (11) and can be used to build fully functional replacement for bones or organs 
(24). The demand for 3D printing is expected to increase due to their ability to make custom 
medical devices, produce scaffolds in a reproducible and controlled manner that improves 




1.6. Cell/tissue-scaffold interactions 
 
Optimizing cell-tissue scaffold material interactions are one of the main goals for tissue 
engineering. Cell-to-cell contact between cells and scaffold is required to stimulate the initial 
attachment, while cell spreading and cell growth may be  influenced by surface texture (47), 
with a clear relationship between surface roughness of biomaterials and cell proliferation, 
adhesion, and morphology (48, 49). Further, the expression of adhesion proteins varies with 
respect to the surface roughness. (17, 47-49). 3D printed scaffolds are of interest as they can 
be processed into a variety of shapes and sizes for ideal attachment and growth. High porosity   
and high interconnectivity are essential to increase scaffold surface area for cell attachment 
and tissue ingrowth (50, 51), and 3D printed scaffolds can be made with different pore size, to 
accommodate the different pore size that may be required for different cells. Physical and 
chemical properties of the scaffold surface are also crucial for the cell-material interaction 
(52-55). 3D structure can be varied in many ways, as cell proliferation and distribution may 
be affected by many structural factors.  
Recently, the use of 3D bio-plotter system has been used in tissue engineering (56). 
Different designs of the 3D scaffolds, different angles of rotation (45° and 90°), and scaffold 
characteristics have been shown to promote initial cell attachment and differentiation (46, 57, 
58). Therefore, the aims of this study was to evaluate 3D printed scaffolds for bone tissue 
engineering (BTE) using two modified 3D printed scaffolds with different pore size (1000 µm 
and 1200 µm) and to investigate the effect of these scaffolds on cell viability, attachment, 




2. Aims  
 
The main objective of this study is: 
 To develop three dimensional (3D) printed scaffold in a reproducible and controlled manner. 
The specific aim of this study is: 
To investigate the effect of the 3D printed scaffolds developed on the following: 
• Protein adsorption 
• Cell attachment and morphology 
• Cell viability and apoptosis 
• Cell proliferation  












3. Materials and Methods 
 




Aliphatic thermoplastic poly (L-lactide-co-caprolactone) (PLCL, PURASORB® PLC 7015, 
CORBION, The Netherlands), synthesized from L-lactide and ε-caprolactone monomers with 
a molar ratio of 70/30 was used to produce the scaffolds. PLC 7015 has an inherent viscosity 
between 1.2-1.8 dl/g, and a maximum residual amount of tin of 100 ppm.  The material was 
used as purchased.  
3.1.2. Scaffold design 
 
Scaffold dimensions chosen for the design were 11.5mm (diameter) x 2.5mm (thickness) in 
order to fit in a standard 48-well cell culture plate. The layer distance was 340 µm in order to 
offer solid layer integration and adequate mechanical support. First, two designs with simple 
inner structures were printed. The first pattern had a rotational angle of 0/90 between each of 
the two layers and the second pattern had rotational angles of 0/45 degree (Fig.4A and 4B). 
These scaffolds were used to optimize both the printing process parameters and cell culture. 




 rotational patterns were developed for this study. Pattern 1 had a 
strand distance of 1 mm between the first and second layers (L1/L2), and 0.71 mm between 
the third and fourth layers (L3/L4), while pattern 2 had a strand distance of 1.2 mm between 
L1/L2 and 0.86 mm between L3/L4. Every two connecting layers (L1/L2 or L3/L4) had a 90
o
 
cross rotation relative to each other. A rotation of 45
o
 between L1/L2 and L3/L4 layers was 





 patterns with top-to-bottom cross point connections was built. This pattern has been 
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shown to have the capacity to sustain high compressive load force from the z axis (46) 
(Fig.5).  
3.1.3. Scaffold fabrication 
 
Scaffolds were produced by three-dimensional plotting method (3DP) method using a 3D 
Bioplotter system (4
th
 generation, EnvisionTec GmbH, Germany).  For each printing job, 
approximately 0.6 g of PLCL was loaded into a steel cartridge and heated to 175°C for 20 min 
until the polymer melted and stabilized. The cartridge was then heated up to 195°C for 
constant extrusion under a pressure of 6 bars. A 24G Luer lock stainless steel nozzle with an 
external diameter of 700 µm, and internal diameter 400 µm were used to extrude strands 
according to the design controlled by computer (Fig. 6). The pores of the two modified 
patterns of 3D printed scaffolds (1000 µm and 1200 µm) are investigated using the LEICA 
M205C microscope (Leica, Germany). 
 




Figure 5. Scheme of plotting and scaffold design.  
 
Figur 6. The 3D Bio-plotter system:  (1) high temperature cartridge loaded on the pocket; (2) 
printing plate, equipped with a cooling pad; (3) the robot arm installed with a height sensor 






3.1.4. Sterilization  
 
Cleaning of the scaffold was accomplished by using 75% ethanol alcohol for 15 minutes and 
keeping them dry overnight in a clean cabinet (hood) under UV light until further analysis 
was performed. 
3.2. Characterization of scaffold  
 
3.2.1. X-ray micro-computed tomography 
 
For quantitative evaluation of surface area and porosity of the scaffolds, µ-CT scans were 
performed using the SkyScan1172
VR
 microfocus X-ray system (SkyScan
VR
, Kontich, 
Belgium) with the CTAn 1.8
VR
 and NRECON RECONSTRUCTIONVR CT software 
(SkyScan
VR
). No filter was used to generate the images. Source voltage and current were set 
at 40 kV and 250 µA, respectively. After operating CTAn 1.8
VR
 to each reconstructed BMP 
files, surface area, total porosity percentage and open porosity percentage values were 
obtained. 
3.2.2. Protein adsorption 
 
The 3D printed scaffolds (n=3/group) were placed in 48-well culture plates and rinsed three 
times with phosphate-buffered saline solution (PBS). Then 1 ml minimum essential medium, 
alpha modification (ᾳ-MEM Gibo Grand Island, NY, USA) supplement with 1% antibiotics 
(penicillin/ streptomycin, Gibco) and containing 10% fetal bovine serum (FBS, Gibco) was 
added to each well. After incubating at 37 ᵒC for 2 h, the scaffolds were rinsed with 1 ml PBS 
for three times to remove the loosely adsorbed proteins. The scaffolds were then transferred to 
another 48-well plate and incubated with 500µl of PBS containing 2.0 wt. % sodium dodecyl 
sulfate (SDS) for 20 h to remove proteins adsorbed on the scaffold surface. The total protein 
concentration values in the solutions were quantified by means of a commercial protein assay 
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kit (BCA; Pierce, Rockford, IL, USA) following the manufacturer’s instructions and a 
microplate reader (FLUOstar optima, BMG LABTECH, Germany) at 530 nm of absorbance.  
3.3. Cell cultures and scaffold seeding 
 
To study the cellular reaction on each scaffold surface, HOBs and the mouse fibroblast cell 
line L929 (American Type Culture Collection CCL 1, Manassas, VA, USA) were used. HOBs 
were obtained from fresh human mandibular bone specimens, with no clinical or radiographic 
evidence of pathology, obtained from patients undergoing routine oral surgery at the 
Department of Maxillofacial Surgery, Haukeland University Hospital and Department of 
Clinical Dentistry, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. 
The study protocol for the use of HOBs was approved by The Regional Committees for 
Medical and Health Research Ethics (REK), Western Norway (2609/610). 
The tissue sample was taken from the molar region, washed with (PBS) and digested using 
collagenase (1mg/mL) in serum-free culture medium using a modification of the method 
described by Beresford (59). The cells were then characterized using different assays (49). 
          HOBs were cultured in ᾳ-MEM supplement with 1% antibiotics and 10% FBS and 
incubated at 37˚C, 5% CO₂, 95 % humidity until 80% confluence was reached. Three donors 
with cells from passages 2-5 were used for all studies. Culture medium was changed twice a 
week. Proliferation of HOBs at 24 hours up to 14 days is shown in Fig.7. Cells were 
trypsinized and counted using a Countess
TM
 Automated Cell Counter (Invitrogen
TM
, Carlsbad, 




 pattern 3D 
printed scaffolds with different distances between the printed fibers (1000µm, 1200µm) were 
tested. Scaffolds were soaking for 24 hours in ᾳ-MEM supplemented with 1% antibiotics and 
10% FBS, then incubated in 5% CO2 at 37°C. Thereafter, HOBs were seeded onto the various 





cells/scaffold for use in the cell proliferation (MTT) assay and 2x10
5
cells/scaffold for 
SEM, RNA, L&D, and LDH assays in 48-well plate (Thermo Scientific – nunc, Denmark) for 
1, 3, 7, and 14days. Culture medium was changed twice a week.  
   The mouse fibroblast cell line L929 was used to optimize scaffold design for 




scaffolds. L929 cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM, Gibco) containing 2 mM L-glutamine (PPA Laboratories 
GmbH, Pasching, Austria) supplemented with 10% (FBS) and 1% antibiotics at 37 °C in a 
humid atmosphere containing 5% CO2 for 1,3 and 7 days.  
 
         
Figure 7. Proliferation of human osteoblasts showing the number of cells after (a)  24 hrs; (b) 
3 days;  (c) 7 days;  (d) 14 days, when the cells reached 80% confluence.  
3.3.1. Scanning electron microscopy (SEM)  
 
The HOBs/ scaffolds were fixed in 3% glutaraldehyde for 30 minutes, then washed in 0.1 M 
Na-cacodylate buffer PH 7.4 for 10 min. The samples were then fixed in 1% osmium 
tetroxide (OsO4) in 0.1 M Na-cacodylate buffer without sucrose for 60 min, followed by 
washing in buffer without sucrose for 2x 5 minutes, then washed with distilled water for 5 
min and dehydrated in graded ethanol. Critical point drying was carried out and the samples 
were coated with a 10 nm conducting layer of gold/platinum. The topography of the scaffolds’ 
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surface and cellular morphology were examined in a Jeol JSM (JSM -7400F, Tokyo, Japan) 
operating at a voltage of 10 kV. 
3.3.2. Live and Dead assay (L&D) 
 
cells viability and cytotoxicity were examined using Live/Dead
®
Viability/Cytotoxicity Kit 
(molecular probes by life technology, North America, USA) and 2x10
5 
cells/scaffold grown in 
a 48-well plate and incubated in 5% CO2 at 37°C for 1, 3, and 7 days. Culture medium (ᾳ-
MEM, Gibo) was changed twice a week. For L&D assay the culture medium was replaced 
with 600 ml per well from a mixture of (10 ml BPS + 2µl calcain AM (white color for 
detection live cells) + 4µl ethidium homodimer-1 (red color for detection dead cells). Cultures 
were incubated for 35 min and evaluated by fluorescence microscopy (Nikon Eclipse 80i, 
equipped with 4x, 10x and 20x, Japan).  
3.3.3. Lactate dehydrogenase assay (LDH) 
 
Cellular death was also evaluated by measuring the release of LDH from the cells after culture 
days 1, 3, 7 and 14. The HOB cells were seeded onto scaffolds and placed in 48-well cell 
culture plates (2x10
5
cells/scaffold) in ᾳ-MEM medium, and at each time point the medium 
was discarded and the cells/scaffolds constructs were washed twice with PBS. Attached cells 
were lysed with 1% Triton X-100 in PBS for 50 minutes on ice. The released LDH in the cell 
lysate was measured with a colorimetric LDH detection kit (Abcam, ab102526, Cambridge, 
UK) according to the manufacturer’s instructions. After incubation for 30 min at 37ºC the 






3.3.4. Methylthiazol tetrazolium (MTT) assay  
 
The MTT mitochondrial reaction was used to analyze cell proliferation and viability. This is a 
tetrazolium-based colorimetric assay based on the ability of living cells to reduce yellow 
tetrazolium dye (Sigma, St Louis, MO, USA) to a purple colored formazan compound (60). 
HOBs were seeded onto scaffolds at 1x10
5
cells/scaffold and incubated for 1, 3 and 7 days. 
Cells/scaffold constructs were washed with PBS then 500µl MTT reagents (2ml stock of 
MTT+ 4ml of complete medium) was added to each sample and incubated for 3 hours at 
37°C, under a CO2 (5%) atmosphere. The MTT reagent was removed and cells/scaffold 
constructs were fixed with Tris-formaline for 5 minutes, washed with distal water and air 
dried, covered with foil and kept for one day in a dark place. The formazan product was 
solubilized in 0.5 ml DMSO containing 6.25% (v/v) 0.1 M NaOH 500µl for each well by 
shaking on vibrator for 20 minutes. The end product was quantified by microplate 
spectrophotometry (BMG LABTECH, GmbH, Germany) at a wavelength of 570 nm and 
expressed as optical density (OD) units after blank subtraction. 
3.4. QRT-PCR gene expression 
 
HOBs were seeded onto scaffolds, placed in 48-well plate with ᾳ-MEM culture medium, and 
allowed to incubate in 5% CO2 at 37°C for 1, 3, 7, and 14 days for apoptosis assay and 14 
days for ALP and OC assay. Culture medium was changed twice a week. At each time point, 
cells/scaffold were washed with PBS twice and kept in -80°C for further analyses. Total RNA 
was isolated (from four independent biological replicas) at different culture times using 
Maxwell® 16 LEV simply RNA Tissue Kit protocol (Promega, Madison, USA), following 
the manufacturer’s instructions. The quantity and quality of the extracted RNA were checked 
by spectrophotometry. A reverse transcription reaction was performed using the High-
Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA), using 300 ng of 
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the total RNA dissolved in 40µl nuclease-free water mixed with reverse transcriptase (RT) 
buffer, random primers, dNTPs and MultiScribe™ RT(ThermoFisher). 
Quantitative real-time PCR assays were performed with the ABI StepOnePlus
TM
 
RealTime PCR System (Applied Biosystems, Foster City, USA). In each of the RNA samples 
the GAPDH: Hs99999905_m1 (Applied Biosystems, ThermoFisher Scientific) was used as a 
reference housekeeping gene. PCR amplification of the selected markers was done in 
duplicate with 10 µl reaction volume PCR reactions contained 0.5 µl of TaqMan
TM
 
(ThermoFisher Scientific) for apoptotic and bone markers (Bax: Hs00180269_m1, Bcl2: 
Hs00153350_m1, ALP: Hs01029142_m1 and OC: Hs00609452_g1), 3.5 µl of nuclease free 
water, 5 µl of TaqMan universal fast PCR master mix (Applied Biosystems, ThermoFisher 
Scientific) and 1 µl cDNA. Thermocycling conditions were 95 ºC for 20 s, followed by 40 
cycles at 95 ºC for 1 s and 60ºC for 20 s. The comparative 2
 −ΔΔ
Ct method (61) was used to 
calculate the gene expression levels of Bax, Bcl2, ALP and OC in each sample. 
3.5. Statistical Analysis 
 
Statistical analysis was performed using IBM SPSS Statistics version 23 (IBM Corp, Armonk, 
NY,USA) software and One Way Analysis of Variance (ANOVA) was performed at different 
time points (Multiple Comparison tests, followed by Tukey Test). The Differences between 
the means were considered statistically significant at P<0.05. Student T-test was performed to 
check the differences in means between the scaffolds for LDH and µ CT test, statistical 





4. Results  
4.1. Scaffold fabrication: 
 
Two different scaffold designs were produced with a layer rotation of 45° and 90° and a 
distance of 1000 µm and 1200 µm between the printed fibers as shown in Fig.8. 
 
 
Figure 8. The pores of the two modified patterns of 3D printed scaffolds (1000 µm and 1200 
µm) are shown using the LEICA M205C microscopy. 
 
4.2. Characterization of scaffolds 
 
 
4.2.1. Microcomputed tomography analysis (µCT) 
 
The interconnected pore structure of the scaffolds was analyzed by µCT, the total porosity 
(%), open porosity (%), and surface area (mm
2
) are shown in Table 1 and 2 and Fig. 9, 10, 11 
and 12. There was no statistically significant difference between the two designs, although the 





Table 1. µCT analysis of the 1200 µm 3D printed scaffold. 
 




Figure 9. Reconstructed µCT figure confirming the open, porous structure of the printed 
scaffolds. 
 
1200 Sample 1 Sample 2 Sample 3 Average SD
Total volume (mm3) 135 115 137 129 12,16553
Object volume  (mm3) 67,9 48 63,8 59,9 10,50762
Percent object volume 50,2 41,6 46,5 46,1 4,313931
Object surface (mm2) 634,7 519,8 611,8 588,7667 60,8145
Closed porosity (%) 0,14 0,14 0,04 0,106667 0,057735
Open porosity (%) 49,6 58,2 53,4 53,73333 4,309679
1000 Sample 1 Sample 2 Sample 3 Average SD
Total volume (mm3) 114,6 172,3 184,2 157,0333 37,22692
Object volume  (mm3) 68,4 125,8 121,4 105,2 31,94558
Percent object volume 59,6 73 65,9 66,16667 6,703979
Object surface (mm2) 646,9 741 792,8 726,9 73,96492
Closed porosity (%) 0,2 0,3 0,2 0,233333 0,057735




Figure 10. µCT analysis of total porosity% for two scaffold designs  
 
 





Figure 12. µCT analysis of surface area mm
2
 for two scaffold designs  
4.2.2. Protein adsorption 
 





patterns (1000 µm, 1200 µm) was determined. The results showed only a slight difference in 




 pattern (1000 
µm, 1200 µm) 3D printed scaffolds (Fig.13). Although the scaffold with 1200 µm distance 
between the fibers demonstrated more protein adsorption than the 1000 µm scaffolds, it was 




Figure 13. Protein adsorption on the surface of the two printed scaffolds  
4.3. Cellular activities 
4.3.1. Cell proliferation  
 




) 3D printed 
scaffolds for 1, 3 and 7 days for optimization of the proliferation of cells on the scaffolds. The 
MTT results showed an increase in the proliferation of cells from day 1 to day 7 on scaffolds 
compared to the 2D control (48 well-plates) (Fig.14 and 15). Higher MTT activity was shown 
















4.3.2. Cell morphology and cell attachment 
 
SEM images of cell morphology showed that after incubation for 1 day HOBs were attached 
to the inner layers of the two modified designs and had normal osteoblast morphology. After 
incubation for 3 days the HOBs were evenly distributed on the surfaces of the two scaffolds 
and cells had migrated to the middle of the scaffolds. After incubation for 7 and 14 days 
HOBs were confluent on the two scaffolds’ surfaces (Fig.16).  
                                                                                                                                                                             
Figure 16. SEM images of scaffolds cultured with HOBs. Magnification 50× of 1000 µm 
(a1, c1, e1, g1) and 1200µm (b1, d1, f1, h1) 3D-printed scaffold cultured for 1, 3, 7, and 
14 days respectively. Magnification 350× of 1000 µm (a2, c2, e2, g2) and 1200µm (b2, 
d2, f2, h2) 3D-printed scaffold cultured for 1, 3, 7, and 14 days respectively. 
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      4.3.3. Cell viability Live / dead assay 
 
The L&D assay carried out using calcein/ethidium staining after seven days of culture 
(Fig.17), showed most of the cells exhibiting green rather than red fluorescence, 
indicating cell viability. Cells showed normal osteoblast morphology on both scaffolds.  
 
 
Figure 17. Fluorescence microscopy images of human osteoblast cells after staining with 
fluorescencein (green-live cells) calcain AM and ethidium homodimer-1(red-dead cells). (a,b) 
HOB proliferation in 3DP scaffold 1000 day 1, (c,d) 1200 day 3,(e) 1000  day 3, (f) 1000 day 
7, (g) 1200 day 7,(h) HOB in control day 7. 
 
4.3.4.  LDH assay 
 
The cytotoxicity of 3D printed scaffolds evaluated by the LDH assay showed HOBs were able 
to grow and proliferate well (Fig.18). Statistically there was no significance difference 





Figure 18. LDH cytotoxicity assay.  
 
      4.3.5. MTT assay 
 
As shown in Fig. 19, the MTT assay indicated that the 3D printed scaffolds enhanced cell 
proliferation, with no significant difference between 1200 and 1000 3D printed scaffolds.  
                 





4.4. qRT-PCR  
4.4.1. Apoptosis 
 
The results for the cell death assay (Fig. 20) demonstrated no statistical significant difference 
between the mRNA expression of Bax by HOBs seeded onto 1000 µm and 1200 µm fiber 
separation scaffolds at days 1,3, 7 and 14 (P>0.05). However, significant differences were 
observed between mRNA expression of Bcl2 by HOBs seeded onto 1000 µm and 1200 µm 
scaffolds at days 1, 3, 7 and 14 (P<0.05).  At all these time-points, better cell viability and 
decreased cell death was seen with the 1200 µm scaffolds.    
 
 
Figure 20. Gene expressions of Bax and Bcl2 from HOBs seeded on 3D printed scaffolds 
(1000 and 1200 µm) 
4.4.2. Bone markers 
 
To evaluate osteogenic differentiation on the two scaffolds, the mRNA expression of ALP 
and OC were determined at day 14 using probes specific for each gene normalized to the 
housekeeping gene GAPDH. ALP and OC expression from cells on the 1200 µm scaffolds at 
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day 14 were higher than on the 1000 µm scaffolds, although there was no significant 
difference found at day 14 between mRNA levels of ALP of HOBs seeded onto 1000 µm and 
1200 µm scaffolds. On the other hand, there was a statistically significant difference between 
mRNA levels of OC of HOBs seeded onto 1000 µm and 1200 µm at day 14 (P<0.05) (Fig. 




Figure 21.  ALP and OC expression from HOBs seeded on 3D printed scaffolds (1000 µm 






Recently, 3D printing has emerged in the tissue engineering field as a new tool for the 
fabrication of scaffolds to produce well-defined and reproducible architectures. 3D printing 
allows the building of custom-made scaffolds based on patient-specific tissue defects. These 
3D printed scaffolds also provide good in vitro platforms for studying the effects of 
geometry/architecture on cellular responses, hopefully leading to improved mechanical 
performance of bioengineered scaffolds. The ‘‘printing’’ process involves many interactions 
between hardware, software and material properties. Therefore, choosing the right processing 
conditions and the proper materials helps in obtaining reproducible and high quality 3D 
scaffolds. Several degradable polymers such as polycaprolactone, polylactic acid (PLA), 
polyglycolic acid, and their copolymers have been used to fabricate 3D printed scaffolds (62, 
63). The advantages of using a synthetic polymer and their copolymer materials are ease in 
processing into tissue engineering scaffolds and extreme versatility, which allow custom 
tailoring, and the ability to vary biodegradation time, softness, wettability, mechanical 
strength, and biocompatibility (3, 32).  These synthetic polymers have also been approved by 
the US FDA for clinical use, so that PLCL is already in use as a biodegradable polymer for 
tissue engineering applications. Though this polymer has been extensively used to fabricate a 
3D porous scaffold using the salt-leaching method, the use of the 3D printing technique using 
a nozzle based system has rarely been reported (62).  In the present study, 3D scaffolds were 
plotted layer-by-layer with different angles of layer rotation and distances between the printed 
struts. The fiber spacing was fixed at 1mm and 1.2 mm, respectively as shown in Fig. 5. 
Angles of 45
o
 (0/45) and 90
o
 (0/90) rotations were applied between each pair of continuous 
layers (Fig. 4). The angle of 0/45 yielded scaffolds with rhomboid pores while the angle of 
0/90 produced a scaffold with square pores.  The design of these scaffolds was chosen to 
make each layer act as a barrier to the next layer when cell solution flows, to increase the 
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possibility of cell attachment (46). The selected design and material allowed well-defined 
porous scaffolds to be obtained, as observed by light microscope (Fig. 8) and µCT (Fig. 9).  It 
is well known that a scaffold with open porous interconnectivity is a crucial factor for tissue 
engineering applications. Connected pores allow the diffusion of nutrients and cell metabolite 
and improve cellular proliferation and migration (46, 64). Theoretically, the bigger the 
distance between the printed struts, the more open porosity that is obtained.  The results 
obtained from µCt analysis showed that the design with a distance of 1200 µm between fibers 
had more open porosity when compared to 1000 µm.  During the printing process, it is 
possible that some fusion between the struts and the underlying layers occurred with the 
smaller distance between fibers, perhaps explaining why µCT evaluations of porosity of the 
1000 µm design were lower than the 1200 µm.  
A biocompatible scaffold with appropriate surface properties such as surface area and 
wettability is important for protein adsorption, which is a crucial step in the bone regeneration 
process. The first event that takes place when a scaffold is implanted in vivo, after the initial 
hydration, is protein adsorption on the surface. This step drives subsequent cell adhesion, 
followed by proliferation and/or differentiation (65). Li et al. (66) showed that high specific 
surface area scaffold architecture can increase protein adsorption. In this study, however, we 
found no significant difference in protein adsorption on the surface of the printed scaffolds 
between the two designs. This result is in agreement with the results of surface area obtained 
from µCT analysis (Tables1 and 2). 
The cytotoxicity and biocompatibility of scaffolds made of poly (L-lactide-co-
caprolactone) have previously been evaluated by culturing L929 mouse cells and HOBs (35), 
and cell proliferation and expression of apoptotic markers were consistent with good 
biocompatibility of the scaffolds. In the present study, the 3D printed scaffolds again 
demonstrated good biocompatibility and provided greater surface area for cell growth than the 
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2D tissue culture plates. The MTT assay of cultured HOBs on the modified scaffolds showed 
no significant difference between the 1000 and 1200 µm versions. This could be due to the 
comparable surface area of the two designs as shown in the µCT study (Fig. 12).  
         SEM analysis shows that HOB cells responded well to the two versions of the 3D 
printed scaffolds, with good attachment, proliferation (day 1 to 7), even distribution and 
formation of multicellular layers (day 14) which entirely covered the scaffolds (Fig. 16).       
A previous study performed by our group on the same scaffold design compared the 3D 
printed scaffolds with salt leached scaffolds, and showed that the homogeneous cell 
distribution on 3D printed scaffolds provides improved nutrition that facilitates the spreading 
and proliferation of the HOBs  relative to that seen on the salt-leached scaffolds (36, 41, 46).  
The viability of cells on the 3D printed scaffolds was investigated using the 
Live/Dead
®
Viability/Cytotoxicity Kit. The fluorescence microscopy images of the 3D printed 
scaffolds at 7d after being seeded with HOBs is shown in Fig.17 (live cells are green and red 
cells are dead). This type of assay allows the detection HOBs on the 3D printed scaffolds, 
and, in agreement with the previous study by Oliveira et al (67) demonstrated adhesion, 
proliferation and viability after 7 days in culture with no significant difference between the 
two versions of the scaffolds. Furthermore, it can be seen that HOBs penetrated deep in 
between the layers of the two modified designs of the 3D printed scaffold.  
        The LDH assay was used to detect cell death by measuring the release of LDH from the 
cells when the cell membrane of the HOBs was damaged. The LDH assay was used as 
another measure of cell viability and proliferation at different time points.  No statistically 
significant differences were seen for the two versions of the 3D printed scaffolds (Fig.18), in 
agreement with a previous study (68). The results demonstrated the biocompatibility of the 
two types of scaffolds in vitro, promoting HOB proliferation without cytotoxic effect (35).   
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Enhanced growth of HOBs on the two versions of the 3D printed scaffolds was seen and 
clearly demonstrated by the MTT assay (Fig. 19).  Cell growth and proliferation on the 1200 
µm 3D printed scaffolds was better than on the 1000 µm 3D printed scaffold.  MTT analysis 
disclosed that HOBs had responded well to both the 1000 µm and 1200 µm PLCL scaffolds, 
and there was a continual increase of cells on 3D printed scaffolds up to day 7 with no 
statistically significant difference between the two designs. These results are in agreement 
with a previous study by Sun et al (46) in that their 3D printed scaffolds, made from 
biodegradable poly (L-lactide-co-caprolactone), were also biocompatible with HOB cells, did 
not inhibit attachment and allowed proliferation of cells.  
Apoptosis, or programmed cell death, involves both Bcl2 (an anti-apoptotic gene) and 
Bax (a pro-apoptotic gene) (28, 69). Apoptotic activity in HOBs on the 3D printed scaffolds 
was examined by quantitative real time RT-PCR. Our results showed that the mRNA 
expression level of Bcl2 measured by qRT-PCR on days 1, 3, 7 and 14 increased, while 
mRNA expression level of Bax decreased in both scaffold version, indicating that the 
apoptotic activity did not increase in the cells seeded onto the modified 3D printed scaffolds 
i.e. there was continuous increase in cell viability and decrease in cell death. Moreover, the 
mRNA expression level of Bcl2 was higher in cells seeded onto the 1200 µm scaffold 
compared to 1000 µm. Our data is in agreement with a previous study that showed similar 
reduction of apoptotic activity when the same cells were seeded on similar copolymer 
material scaffolds (35). 
           To further evaluate the in vitro osteogenic potential of the two versions of the 3D 
printed scaffolds, the bone markers ALP and OC were tested at day 14 using qRT-PCR. The 
results showed higher expression of mRNA of ALP and OC by HOBs grown on the 1200 µm 
than by HOBs grown on the 1000 µm 3D printed scaffolds.  ALP is considered an early 
marker of osteoblast differentiation (19), and OC a late marker of bone formation, or a mature 
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differentiation marker, in HOBs (19). The modified 3D printed scaffolds supported better 
expression of the early and late osteoblast markers ALP and OC, respectively, possibly 
because of the modified design that stimulated osteogenic differentiation. Falguni et al (70) 
reported an increase in ALP and OC by human inferior turbinate nasal tissue-derived 
mesenchymal stromal cells cultured on cell-laid mineralized extracellular matrix-ornamented 
3D scaffolds at day 7 and 14. 
The presented study showed that the two 3D printed copolymer scaffolds versions 
(1000 µm and 1200 µm) are biocompatible with HOBs, and do not impair cell attachment or 
proliferation. Cell viability and apoptosis assays reflected good cell growth and proliferation. 
Enhanced osteoblast proliferation and differentiation were demonstrated by increased mRNA 
expression of ALP and OC. Therefore, the HOBs/1200 µm scaffolds warrant further 






PLCL scaffolds were successfully produced with a 3D printer and the two different designs   
investigated in this study demonstrated comparable porosity and surface area. The HOB cells 
attached, spread and proliferated well onto the 3D printed PLCL scaffolds. Cell viability and 
apoptosis assays demonstrated good cell growth and proliferation. Osteoblast proliferation 
and differentiation were demonstrated by increased mRNA expression of the ALP and OC 
genes. Compared to the 1000µm scaffold, the 1200µm scaffold supported better osteoblast 
maturation and increased the secretion of bone matrix, which aids in bone engineering. 
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